2006 Annual Session - Exciting Research Advances (ERA): Immunology and Pulmonary/Critical Care
American College of Physicians
American College of Physicians  
Home Topics Events Presenters Specials Help
Search:  

2008 Topics

Additional Topics
Associates, Residents and Fellows in Training
Cardiology
Career and Professionalism
Clinical Pearls
Computer in Practice
Clinical Pharmacology
Ethics and Health Policy
Endocrinology
Gastroenterology and Hepatology
Health Issues Related to Age and Gender
Hematology
Hospital Medicine
Infectious Diseases
Medical Practice Management
Multiple Small Feedings of the Mind
Nephrology and Hypertension
Neurology
Oncology
Ophthalmology and Otolaryngology
Perioperative Medicine
Pre-Session Courses
Psychiatry
Pulmonary Diseases and Critical Care
Rheumatology and Allergy & Immunology
Updates

2006 Annual Session


Exciting Research Advances (ERA): Immunology and Pulmonary/Critical Care

Session #: 856-215
Presenter(s): Stanley A. Schwartz, PhD, MD; Robert A. Klocke, MD, FACP; Alan R. Leff, MD
Session Length: 1:00 hr
Event: 2006 ACP Annual Session
Date: April 6-8, 2006

Purchase Media - Session #: 856-215
Description Price Qty. Cart
 CD $17.00 buy now  
 MP3 $17.00 buy now  
 iPod Audio $17.00 buy now  

Clinical questions to be addressed:
Treatment for the Severe Asthmatic Patient
This lecture outlines two potentially novel approaches still in early stages of development. Bronchial thermoplasty is a procedure by which an expandable thermal "basket" can be inserted into the airways of asthma patients. A second new line of treatment examines the potential role of inter- and extracellular phospholipases (phospholipase A2), which regulate the inflammatory responses in the lung.
Reversible Airway Obstruction
Asthma has long been associated with reversible airway obstruction. We now recognize that asthma is a chronic inflammatory disorder affecting the lungs that can lead to persistent changes in the pulmonary parenchyma known as remodeling. Recent studies have demonstrated that a family of enzymes, the matrix metalloproteinases, can be activated during inflammatory diseases such as asthma, resulting in breakdown of the extracellular matrix. A secondary host response to this activity is the deposition of various types of collagen, resulting in significant changes in various pulmonary functions. This presentation will discuss how matrix metalloproteinases can be activated and what measures may be taken prophylactically to avoid pathologic remodeling of normal lung tissue.




About     |   Contact Us   |   FAQ   |   Order Process   |   Privacy Policy   |   Shipping Policy   |   Your Account   |   Login   |   View Cart
© Copyright 2006 iPlayback. All Rights Reserved.
Developed in and hosted by CommerceV3.